Our results also suggested that endogenous levels of TXNRD1 expression in cancer cells are inversely associated with auranofin's activity, and causally associated with the resistance to auranofin in NSCLC cells. This evidence concerns the gene TXNRD1 and non-small cell lung carcinoma.